Cargando...
98 Monitoring the Safety of Second Generation Antipsychotics in Children and Adolescents with Autism Spectrum Disorder
BACKGROUND: Approximately 17.5% of youth with autism spectrum disorder (ASD) are treated with second-generation antipsychotics (SGAs). While SGAs have been found to reduce irritability and associated behaviours in youth with ASD, a range of side effects has been reported. Therefore, careful monitori...
Gardado en:
| Publicado en: | Paediatr Child Health |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543308/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pch/pxz066.097 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|